Traditional Chinese medicine preparation for treating chronic granulocytic leukemia
A technology of chronic granulocytes and traditional Chinese medicine preparations, which is applied in the direction of medical preparations containing active ingredients, drug combinations, antineoplastic drugs, etc. It can solve the problems of thrombocytopenia, affecting the quality of life of patients, and the high price of interferon. Small size, low toxic price, good curative effect
Inactive Publication Date: 2009-12-09
刘昭前 +1
View PDF0 Cites 5 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
In recent years, hydroxyurea plus interferon has been used. Hydroxyurea is an anti-tumor chemotherapy drug that can easily cause thrombocytopenia, and it needs to be taken consistently for a long time, which affects the quality of life of patients.
Interferon is expensive and unaffordable for most patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0017] A traditional Chinese medicine preparation for the treatment of chronic granulocytic leukemia, weighing 15 g of realgar, 15 g of frankincense, and 15 g of myrrh, crushing, grinding, and sieving through an 80 mesh sieve; the sieved material is fully mixed with 30 g of Indigo Naturalis powder; then weighing 0.3 g of musk , According to the "equal increasing method", fully mix the musk and the aforementioned powder, and divide them into No. 0 capsules, each with 0.5g powder, and it is ready.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to a traditional Chinese medicine preparation for treating chronic granulocytic leukemia, comprising the following raw materials according to parts by weight: 28 to 32 parts of indigo naturalis, 14 to 16 parts of realgar, 14 to 16 parts of mastic, 0.28 to 0.32 part of musk and 14 to 16 parts of myrrh. The traditional Chinese medicine preparation has the characteristics of good curative effect, low toxicity and low price.
Description
Technical field [0001] The present invention relates to Chinese patent medicines, and further refers to oral Chinese medicine preparations with good curative effect on chronic myelogenous leukemia. Background technique [0002] For the treatment of chronic myelogenous leukemia, Mali Langa is the first choice. However, long-term use of Marylan is prone to bone marrow suppression and pulmonary fibrosis. In recent years, hydroxyurea plus interferon has been used. Hydroxyurea is an anti-tumor chemotherapeutic agent, which can easily cause thrombocytopenia, and it needs to be taken for a long time, affecting the quality of life of patients. Interferon is expensive, and most patients cannot afford it. Summary of the invention [0003] The technical problem to be solved by the present invention is to provide a traditional Chinese medicine preparation for treating chronic myeloid leukemia in view of the shortcomings of the prior art, which has the characteristics of good curative effect...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K36/70A61K36/328A61P35/02A61K33/36A61K35/55
Inventor 尹继业杨前生刘志华吴勇军
Owner 刘昭前
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
